
AMWL Stock Forecast & Price Target
AMWL Analyst Ratings
Bulls say
American Well is positioned for strong growth in 2027, with management noting "significant" revenue growth in the year and experiencing triple-digit pipeline growth. Additionally, the company has strong financials, with revenue expected to reach $205 million in 2026 and $203 million in 2027, and EBITDA loss improving to $2 million in 2027. There are potential risks to the company, including potential government spending cuts and customer losses due to consolidation in the healthcare market, but the current regulatory environment, including temporary flexibilities extended to telehealth during the COVID-19 pandemic, provides a potential tailwind for the company. The company's strategic restructuring and focus on its core markets, along with cost reductions and divestitures of non-core assets, position it for future success and the potential for positive operating cash flow by the end of 2026.
Bears say
American Well is facing increased competition in the digital healthcare market, leading to a decline in revenue and profitability. Additionally, the company's high level of debt and potential liabilities from contingent considerations pose a significant risk to its financial stability in the future. Overall, these factors contribute to a negative outlook for the company's stock.
This aggregate rating is based on analysts' research of American Well Corporation and is not a guaranteed prediction by Public.com or investment advice.
AMWL Analyst Forecast & Price Prediction
Start investing in AMWL
Order type
Buy in
Order amount
Est. shares
0 shares